Literature DB >> 10398124

D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.

J Bartkova1, E Rajpert-de Meyts, N E Skakkebaek, J Bartek.   

Abstract

D-type cyclins are proto-oncogenic components of the 'RB pathway', a G1/S regulatory mechanism centred around the retinoblastoma tumour suppressor (pRB) implicated in key cellular decisions that control cell proliferation, cell-cycle arrest, quiescence, and differentiation. This study focused on immunohistochemical and immunochemical analysis of human adult testis and 32 testicular tumours to examine the differential expression and abundance of cyclins D1, D2, and D3 in relation to cell type, proliferation, differentiation, and malignancy. In normal testis, the cell type-restricted expression patterns were dominated by high levels of cyclin D3 in quiescent Leydig cells and the lack of any D-type cyclin in the germ cells, the latter possibly representing the only example of normal mammalian cells proliferating in the absence of these cyclins. Most carcinoma-in-situ lesions appeared to gain expression of cyclin D2 but not D1 or D3, while the invasive testicular tumours showed variable positivity for cyclins D2 and D3, but rarely D1. An unexpected correlation with differentiation rather than proliferation was found particularly for cyclin D3 in teratomas, a conceptually significant observation confirmed by massive up-regulation of cyclin D3 in the human teratocarcinoma cell line NTera2/D1 induced to differentiate along the neuronal lineage. These results suggest a possible involvement of cyclin D2 in the early stages of testicular oncogenesis and the striking examples of proliferation-independent expression point to potential dual or multiple roles of the D-type cyclins, particularly of cyclin D3. These findings extend current concepts of the biology of the cyclin D subfamily, as well as of the biology and oncopathology of the human adult testis. Apart from practical implications for the assessment of proliferation and oncogenic aberrations in human tissues and tumours, this study may inspire further research into the emerging role of the cyclin D proteins in the establishment and/or maintenance of the differentiated phenotypes. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398124     DOI: 10.1002/(SICI)1096-9896(199904)187:5<573::AID-PATH289>3.0.CO;2-H

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Biological markers of cisplatin resistance in advanced testicular germ cell tumours.

Authors:  Adelaida García-Velasco; Ignacio Durán; Elena García; Miquel Tarón; Claudio Ballestín; Daniel Castellanos; Hernán Cortés-Funés; Luis Paz-Ares
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

2.  Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing.

Authors:  Catherine Denicourt; Christine A Kozak; Eric Rassart
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Germ cell pluripotency, premature differentiation and susceptibility to testicular teratomas in mice.

Authors:  Jason D Heaney; Ericka L Anderson; Megan V Michelson; Jennifer L Zechel; Patricia A Conrad; David C Page; Joseph H Nadeau
Journal:  Development       Date:  2012-03-21       Impact factor: 6.868

Review 4.  The role and regulation of D-type cyclins in the plant cell cycle.

Authors:  M Meijer
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

Review 5.  [Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

Authors:  A Martinschek; C G Ruf; C Sparwasser; H U Schmelz
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

6.  Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Authors:  Rolf I Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli P Kallioniemi; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

Review 7.  Involvement of cyclins in mammalian spermatogenesis.

Authors:  Qingsheng Yu; Ji Wu
Journal:  Mol Cell Biochem       Date:  2008-05-11       Impact factor: 3.396

Review 8.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

Review 9.  Role of cyclins in controlling progression of mammalian spermatogenesis.

Authors:  Debra J Wolgemuth; Marcia Manterola; Ana Vasileva
Journal:  Int J Dev Biol       Date:  2013       Impact factor: 2.203

10.  Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma.

Authors:  Stephan Ryser; Dominique Glauser; Michelle Vigier; Yong Qiang Zhang; Philippe Tachini; Werner Schlegel; Philippe Durand; Irmgard Irminger-Finger
Journal:  BMC Genomics       Date:  2011-01-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.